Publications

PUBLICATIONS FROM SHIKANOV LAB

39. David A, Green LJ, Shikanov A. Fertility Preservation in 2016: Where Are We? Seminars in Reproductive Medicine, Vol.35, No. 2/2017, pp. 160-166.

38. David A, Day JR, Cichon AL, Lefferts A, Cascalho M, Shikanov A. Restoring Ovarian Endocrine function with Encapsulated Ovarian Allograft in Immune Competent Mice. Annals of Biomedical Engineering, 2016. https://www.ncbi.nlm.nih.gov/pubmed/28028710 Screen Shot 2017-01-15 at 8.13.58 PM

37. Amorim CA, Shikanov A. The artificial ovary: current status and future perspectives. Future Oncology, 2016. http://www.futuremedicine.com/doi/abs/10.2217/fon-2016-0202?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed

Screen Shot 2016-07-11 at 5.16.17 PM

36. Kim J, Perez AS, Claflin J, David A, Zhou H, Shikanov A. Synthetic hydrogel supports the function and regeneration of artificial ovarian tissue in mice. npj Regenerative Medicine, 2016. http://www.nature.com/articles/npjregenmed201610

npjregenmed201610-f5

35. Carrion B, Souzanchi MF, Wang VT, Tiruchinapally G, Shikanov A, Putnam AJ, Coleman RM. The Synergistic Effects of Matrix Stiffness and Composition on the Response of Chondropogenitor Cells in a 3D Precondensation Microenvironment. Advanced Healthcare Materials, 2016http://www-ncbi-nlm-nih-gov.proxy.lib.umich.edu/pubmed/26959641

34. David A, Day JR, Shikanov A. Immunoisolation to prevent graft rejection: current knowledge and future use, Experimental Biology and Medicine, 2016. http://www-ncbi-nlm-nih-gov.proxy.lib.umich.edu/pubmed/27188513

33. Green LJ, Shikanov A. In vitro culture methods of preantral follicles. The Theriogenology, 2016. http://authors.elsevier.com/a/1T6KW,28LgsLNN

1-s2.0-S0093691X16300759-gr3

32. Kim J, Kong YP, Niedzielski SM, Singh RK, Putnam AJ, Shikanov A. Characterization of the crosslinking kinetics of multi-arm poly(ethylene glycol) hydrogels formed via Michael-type addition. Soft Matter, 2016.
LINK

Graphical_Abstract

31. Zhou H, Malik MA, Arab A, Hill MTShikanov A. Hydrogel Based 3-Dimensional (3D) System for Toxicity and High-Throughput (HTP) Analysis for Cultured Murine Ovarian Follicles. PLoS One, 2015.
LINK

HongsPublicationFig1

30. Kim J, Wu B, Niedzielski SM, Hill MT, Coleman RM, Ono A, Shikanov A. Characterizing natural hydrogel for reconstruction of three-dimensional lymphoid stromal network to model T-cell interactions. J Biomed Mater Res A, 2015.
LINK

 

29. Shea LD, Woodruff TK, Shikanov A. Bioengineering the Ovarian Follicle Microenvironment. Annu Rev Biomed Eng, 2013. LINK

The 2014 review “Bioengineering the Ovarian Follicle Microenvironment” was highlighted on the Global Medical Discovery webpage.

28. Lai D, Labuz JM, Kim J, Luker GD, Shikanov A, Takayama S. Simple multi-level microchannel fabrication by pseudo-grayscale backside diffused light lithography. RSC Advances, 2013.
LINK

 


PUBLICATIONS FROM SHEA LAB

27. Smith RM*, Shikanov A*, Kniazeva E, Ramadurai D, Woodruff T, Shea LD. Fibrin-mediated delivery of an ovarian follicle pool in a mouse model of infertility. Tissue Eng Part A, 2014.

LINK

26. Weiss MS, Bernabé BP, Shikanov A, Bluver DA, Mui MD, Shin S, Broadbelt LJ, Shea LD. The impact of adhesion peptides within hydrogels on the phenotype and signaling of normal and cancerous mammary epithelial cells. Biomaterials, 2012.
LINK

25. Shepard JA, Stevans AC, Holland S, Wang CE, Shikanov A, Shea LD. Hydrogel design for supporting neurite outgrowth and promoting gene delivery to maximize neurite extension. Biotechnol Bioeng, 2012.
LINK

24. Shikanov A, Zhang J, Xu M, Smith RM, Rajan A, Woodruff TK, Shea LD, Fibrin Encapsulation and VEGF Delivery Promotes Ovarian Graft Survival in Mice, Tissue Eng Part A, 2011.
LINK

23. Shepard JA, Wesson PJ, Wang CE, Stevans AC, Holland SJ, Shikanov A, Grzybowski BA, Shea LD. Gene therapy vectors with enhanced transfection based on hydrogels modified with affinity peptides. Biomaterials, 2011.
LINK

22. Shikanov A, Xu M, Woodruff TK, Shea LD, A Method for Ovarian Follicle Encapsulation and Culture in a Proteolytically Degradable 3 Dimensional System, Journal of Visualized Experiments (JoVE), 2011.
LINK

21.Shikanov A*, Smith RM*, Xu M, Woodruff TK, Shea LD, Hydrogel network design using multifunctional macromers to coordinate tissue maturation in ovarian follicle culture, Biomaterials, 2011, (* equal contribution).
LINK

20.Xu M, Fazleabas AT, Shikanov A, Jackson E, Barrett SL, Hirshefeld-Cytron J, Kiesewetter SE, Shea LD, Woodruff TK, In vitro Oocyte Maturation and Preantral Follicle Culture from the Luteal Phase Baboon Ovary Produce Mature Oocyte, Biol Reprod, 2010.
LINK

19.Shepard JA, Huang A, Shikanov A, Shea LD, Balancing cell migration with matrix degradation enhances gene delivery to cells cultured three dimensionally within hydrogels, J Control Release, 2010.
LINK

18.Jin SY, Lei L, Shikanov A, Shea LD, Woodruff TK, A novel two-step strategy for in-vitro culture of early stage ovarian follicles in the mouse, Fertil Steril, 2010.
LINK

17. Shikanov A, Xu M, Woodruff TK, Shea LD, Interpenetrating Fibrin-Alginate matrices for in vitro Ovarian Follicle Development, Biomaterials, 2009.
LINK

16.dex Rieux A, Shikanov A, Shea LD, Fibrin hydrogels for non-viral vector delivery in vitro, J Control Release, 2009.
LINK


PUBLICATIONS FROM DOMB LAB

15.Shikanov A, Shikanov S, Vaisman B, Golenser J, Domb AJ, Cisplatin tumor biodistribution and efficacy after intratumoral injection of a biodegradable extended release implant, Chem Res Practice, 2011.
LINK

14.Shikanov A, Vaisman B, Shikanov S, DombAJ, Poly(sebacic acid co-ricinoleic acid) biodegradable carrier for intratumoral delivery of paclitaxel, J Biomed Mater Res, Part A,2010.
LINK

13.Slager J, Tyler B, Shikanov A, Domb AJ, Shogen K, Sidransky D, Brem H, Local controlled delivery of anti-neoplastic RNAse to the brain, Pharm Res, 2009.
LINK

12.Shikanov S, Shikanov A, Gofrit O, Nyska A, Corn B, Domb AJ, Intratumoral delivery of paclitaxel for treatment of orthotopic prostate cancer, J Pharm Sci, 2009.
LINK

11.Shikanov A, Shikanov S, Vaisman B, Golenser J, Domb AJ, Paclitaxel tumor biodistribution and efficacy after intratumoral injection of a biodegradable extended release implant, Int J Pharm, 2008.
LINK

10.Vaisman B, Shikanov A, Domb AJ, The isolation of ricinoleic acid from castor oil by salt-solubility-based fractionation for the biopharmaceutical applications, J Am Oil Chem Society, 2008.

9.Shikanov A, Domb AJ, Weiniger CF, Long acting local anesthetic-polymer formulation to prolong the effect of analgesia, J Control Release, 2007.
LINK

8. Shikanov A, Domb AJ, Poly(sebacic acid-co-ricinoleic acid) biodegradable injectable in situ gelling polymer, Biomacromolecules, 2006.
LINK

7. Shikanov A, Ezra A, Domb AJ, Poly(sebacic acid-co-ricinoleic acid) biodegradable carrier for paclitaxel – effect of additives, J Control Release, 2005.
LINK

6. Vaisman B, Shikanov A, Domb AJ, Normal phase high performance liquid chromatography for determination of paclitaxel incorporated in a lipophilic polymer matrix, J Chrom A, 2005.
LINK

5. Shikanov A, Kumar N, Domb, AJ. Biodegradable polymers: An update, Isr J Chemistry, 2005. Review.

4. Shikanov A, Vaisman B, Krasko MY, Nyska A, Domb AJ, Poly(sebacic acid-co-ricinoleic acid)biodegradable carrier for paclitaxel: In vitro release and in vivo toxicity, Journal of Biomedical Materials Research Part A, 2004.
LINK

3. Pawar R, Shikanov A, Vaisman B, Domb AJ, Intravenous and regional paclitaxel formulations, Curr Med Chem, 2004. Review.
LINK

2. Krasko MY, Shikanov A, Ezra A, Domb AJ, Poly(ester anhydride)s prepared by the insertion of ricinoleic acid into poly(sebacic acid), J Polym Sci Part A – Polymer Chemistry, 2003.

1.Kricheldorf HR, Fechner B, Shikanov A, Domb AJ, Polylactones 57. Biodegradable networks based on A-B-A triblock segments containing poly(ethylene glycol)s-syntheses and drug release properties, Biomacromolecules, 2003.
LINK

Pub Med